A Double-blind, Placebo-controlled, Randomized Pilot Trial of The Combination Conjugated Estrogens And Bazedoxifene In Obese Postmenopausal Women
Latest Information Update: 06 May 2019
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary)
- Indications Atrophic vaginitis; Breast cancer; Postmenopausal osteoporosis
- Focus Pharmacodynamics
Most Recent Events
- 06 May 2019 New trial record
- 18 Mar 2019 Results presented at the 101st Annual Meeting of the Endocrine Society